Specialized healthcare Obsidian is a pharmaceutical manufacturing and medical communications specialist with a 20+ year heritage and a client-centric approach, signaling strong partnerships with pharma and healthcare brands that require robust scientific storytelling and regulatory-compliant content delivery.

Small to mid-size focus With 51-200 employees and a demonstrated capability to deliver through a network of 70+ academic scientists and experts, Obsidian can be a scalable partner for mid‑sized biotech and niche pharmaceutical campaigns seeking high-quality, scientifically rigorous materials.

Digital ecosystem The tech stack including WordPress, Smartsheet, CloudFlare and other web tools indicates a strong digital content and project orchestration capability, presenting opportunities for managed content platforms, digital asset management, and streamlined collaboration services.

Clinical communications potential Recent news around Obsidian Therapeutics and advanced cell therapy programs highlights exposure to oncology and immuno-oncology spaces, suggesting sales opportunities in clinical communications, medical affairs support, and patient-centric content for trials and registrations.

Public market visibility Coverage of Obsidian Therapeutics in major outlets and recent funding/transactions suggest readiness to engage in investor-focused quality communications, regulatory updates, and corporate messaging services for growth-stage life sciences entities.